Innate Pharma to share new long-term data on Lumoxiti at 2019 American Society of Hematology annual meeting

NEXT STORY
Bavarian Nordic Announces Interim Results for the First Nine Months of 2019
PREV STORY
 Sorrento to Present New Data on Advanced Immunotherapies at Multiple Upcoming Scientific Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MacroGenics Provides Update on Corporate Progress and 2020 Financial Results

author_avatar
NASDAQ Market News

MacroGenics Announces Closing of MGA012 Global Collaboration and License Agreement with Incyte

ROCKVILLE, MD, Dec. 05, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News

BriaCell Announces Switch to Novel Frozen Formulation for Lead Cancer Drug Candidate, Upcoming Attendance at Biotech Showcase™ 2019 and Presentation at Keystone Symposia Conference

Completed development of a novel frozen formulation of Bria-IMT™ for on-demand shipment to clinical ...

author_avatar
NASDAQ Market News